M. Normand

Low incidence of SARS-CoV-2, risk factors of mortality and the course of illness in the French national cohort of dialysis patients

E. M. Passos, L. Duflot, M. Brahimi, 2020, Kidney International.

Urinary Calcium After Oral Glucose Ingestion in Calcium Stone Formers: A Simple Provocative Test for Predicting Stone Recurrence

J. Bouvet, A. Ulmann, M. Normand, 1989 .

Calciuric response to an acute acid load in healthy subjects and hypercalciuric calcium stone formers.

P. Houillier, P. Jungers, M. Froissart, 1996, Kidney international.

Piridoxilate-induced calcium oxalate calculi: a new drug-induced metabolic nephrolithiasis.

M. Daudon, P. Jungers, M. Normand, 1987, The Journal of urology.

Adverse events associated with currently used medical treatments for cystinuria and treatment goals: results from a series of 442 patients in France

J. Jais, M. Daudon, P. Meria, 2019, BJU international.

CKD and Its Risk Factors among Patients with Cystinuria.

M. Daudon, P. Meria, O. Traxer, 2015, Clinical journal of the American Society of Nephrology : CJASN.

[First-line screening guidelines for renal stone disease patients: a CLAFU update].

A. Hoznek, M. Daudon, P. Meria, 2014, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.